Shaker A. Mousa
DuPont Pharmaceuticals Company
141 & Henry Clay Road
Exp. Station
E400/3470
USA
Name/email consistency: high
- Comparative efficacy between the glycoprotein IIb/IIIa antagonists roxifiban and orbofiban in inhibiting platelet responses in flow models of thrombosis. Mousa, S.A., Abulencia, J.P., McCarty, O.J., Turner, N.A., Konstantopoulos, K. J. Cardiovasc. Pharmacol. (2002)
- Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for Roxifiban. Mousa, S.A., Bozarth, J.M., Naik, U.P., Slee, A. Br. J. Pharmacol. (2001)
- Overview: from heparin to low molecular weight heparin: beyond anticoagulation. Mousa, S.A., Fareed, J. Curr. Opin. Investig. Drugs (2001)
- Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists. Mousa, S.A., Khurana, S., Forsythe, M.S. Arterioscler. Thromb. Vasc. Biol. (2000)
- Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels. Mousa, S.A., Bozarth, J.M., Forsythe, M.S., Slee, A. Cardiovasc. Res. (2000)
- Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: implications for management of vascular disorders. Mousa, S.A. Semin. Thromb. Hemost. (2000)
- Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin. Mousa, S.A., Forsythe, M., Bozarth, J., Jin, F., Confalone, P.N. Coron. Artery Dis. (2000)
- Role of antiplatelet agents in stroke. Mousa, S.A. Curr. Opin. Investig. Drugs (2000)
- Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. Mousa, S.A., Lorelli, W., Campochiaro, P.A. J. Cell. Biochem. (1999)
- Intravenous and oral antithrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban (DMP754) and its free acid form, XV459. Mousa, S.A., Kapil, R., Mu, D.X. Arterioscler. Thromb. Vasc. Biol. (1999)
- Intranasal antiplatelet/antithrombotic efficacy of a novel platelet GPIIB/IIIA receptor antagonist DMP755. Mousa, S.A., Mu, D.X., Hussain, M.A. Thromb. Res. (1998)